 | • レポートコード：MRC2012A8604 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、シンチリマブの世界市場を広く調査・分析し、今後の市場展望をまとめております。シンチリマブの種類別市場規模（10ml、その他）、用途別市場規模（大人、高齢者、子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Innovent、Eli Lilly and Company ・地域別グローバル市場分析 2015年-2020年 ・シンチリマブの北米市場（アメリカ、カナダ、メキシコ） ・シンチリマブのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・シンチリマブのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・シンチリマブの南米市場（ブラジル、アルゼンチン） ・シンチリマブの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：10ml、その他 ・用途別分析：大人、高齢者、子供 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Sintilimab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Sintilimab market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of XX%% in the forecast period of 2020 to 2025 and will expected to reach USD XX million by 2025, from USD XX million in 2019.
Market segmentation
Sintilimab market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Sintilimab market has been segmented into
10 ml
Others
By Application, Sintilimab has been segmented into:
Adult
Senior Person
Children
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sintilimab market presented in the report. This section sheds light on the sales growth of different regional and country-level Sintilimab markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sintilimab market.
The report offers in-depth assessment of the growth and other aspects of the Sintilimab market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Sintilimab Market Share Analysis
Sintilimab competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sintilimab sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sintilimab sales, revenue and market share for each player covered in this report.
The major players covered in Sintilimab are:
Innovent
Eli Lilly and Company
Among other players domestic and global, Sintilimab market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sintilimab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sintilimab, with price, sales, revenue and global market share of Sintilimab in 2018 and 2019.
Chapter 3, the Sintilimab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sintilimab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Sintilimab market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Sintilimab sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Sintilimab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sintilimab Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 10 ml
1.2.3 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Sintilimab Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adult
1.3.3 Senior Person
1.3.4 Children
1.4 Overview of Global Sintilimab Market
1.4.1 Global Sintilimab Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Innovent
2.1.1 Innovent Details
2.1.2 Innovent Major Business
2.1.3 Innovent SWOT Analysis
2.1.4 Innovent Product and Services
2.1.5 Innovent Sintilimab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business
2.2.3 Eli Lilly and Company SWOT Analysis
2.2.4 Eli Lilly and Company Product and Services
2.2.5 Eli Lilly and Company Sintilimab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Sintilimab Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Sintilimab Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Sintilimab Manufacturer Market Share in 2019
3.3.2 Top 6 Sintilimab Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Sintilimab Sales, Revenue and Market Share by Regions
4.1.1 Global Sintilimab Sales and Market Share by Regions (2015-2020)
4.1.2 Global Sintilimab Revenue and Market Share by Regions (2015-2020)
4.2 North America Sintilimab Sales and Growth Rate (2015-2020)
4.3 Europe Sintilimab Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Sintilimab Sales and Growth Rate (2015-2020)
4.5 South America Sintilimab Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Sintilimab Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Sintilimab Sales, Revenue and Market Share by Country
5.1.1 North America Sintilimab Sales and Market Share by Country (2015-2020)
5.1.2 North America Sintilimab Revenue and Market Share by Country (2015-2020)
5.2 United States Sintilimab Sales and Growth Rate (2015-2020)
5.3 Canada Sintilimab Sales and Growth Rate (2015-2020)
5.4 Mexico Sintilimab Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Sintilimab Sales, Revenue and Market Share by Country
6.1.1 Europe Sintilimab Sales and Market Share by Country (2015-2020)
6.1.2 Europe Sintilimab Revenue and Market Share by Country (2015-2020)
6.2 Germany Sintilimab Sales and Growth Rate (2015-2020)
6.3 UK Sintilimab Sales and Growth Rate (2015-2020)
6.4 France Sintilimab Sales and Growth Rate (2015-2020)
6.5 Russia Sintilimab Sales and Growth Rate (2015-2020)
6.6 Italy Sintilimab Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Sintilimab Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Sintilimab Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Sintilimab Revenue and Market Share by Regions (2015-2020)
7.2 China Sintilimab Sales and Growth Rate (2015-2020)
7.3 Japan Sintilimab Sales and Growth Rate (2015-2020)
7.4 Korea Sintilimab Sales and Growth Rate (2015-2020)
7.5 India Sintilimab Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Sintilimab Sales and Growth Rate (2015-2020)
7.7 Australia Sintilimab Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Sintilimab Sales, Revenue and Market Share by Country
8.1.1 South America Sintilimab Sales and Market Share by Country (2015-2020)
8.1.2 South America Sintilimab Revenue and Market Share by Country (2015-2020)
8.2 Brazil Sintilimab Sales and Growth Rate (2015-2020)
8.3 Argentina Sintilimab Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Sintilimab Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Sintilimab Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Sintilimab Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Sintilimab Sales and Growth Rate (2015-2020)
9.3 Turkey Sintilimab Sales and Growth Rate (2015-2020)
9.4 Egypt Sintilimab Sales and Growth Rate (2015-2020)
9.5 South Africa Sintilimab Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Sintilimab Sales and Market Share by Type (2015-2020)
10.2 Global Sintilimab Revenue and Market Share by Type (2015-2020)
10.3 Global Sintilimab Price by Type (2015-2020)
11 Global Sintilimab Market Segment by Application
11.1 Global Sintilimab Sales Market Share by Application (2015-2020)
11.2 Global Sintilimab Revenue Market Share by Application (2015-2020)
11.3 Global Sintilimab Price by Application (2015-2020)
12 Market Forecast
12.1 Global Sintilimab Sales, Revenue and Growth Rate (2021-2025)
12.2 Sintilimab Market Forecast by Regions (2021-2025)
12.2.1 North America Sintilimab Market Forecast (2021-2025)
12.2.2 Europe Sintilimab Market Forecast (2021-2025)
12.2.3 Asia-Pacific Sintilimab Market Forecast (2021-2025)
12.2.4 South America Sintilimab Market Forecast (2021-2025)
12.2.5 Middle East & Africa Sintilimab Market Forecast (2021-2025)
12.3 Sintilimab Market Forecast by Type (2021-2025)
12.3.1 Global Sintilimab Sales Forecast by Type (2021-2025)
12.3.2 Global Sintilimab Market Share Forecast by Type (2021-2025)
12.4 Sintilimab Market Forecast by Application (2021-2025)
12.4.1 Global Sintilimab Sales Forecast by Application (2021-2025)
12.4.2 Global Sintilimab Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Sintilimab Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sintilimab by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sintilimab Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Sintilimab Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Innovent Basic Information, Manufacturing Base and Competitors
Table 9. Innovent Sintilimab Major Business
Table 10. Innovent Sintilimab Total Revenue (USD Million) (2018-2019)
Table 11. Innovent SWOT Analysis
Table 12. Innovent Sintilimab Product and Services
Table 13. Innovent Sintilimab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 15. Eli Lilly and Company Sintilimab Major Business
Table 16. Eli Lilly and Company Sintilimab Total Revenue (USD Million) (2018-2019)
Table 17. Eli Lilly and Company SWOT Analysis
Table 18. Eli Lilly and Company Sintilimab Product and Services
Table 19. Eli Lilly and Company Sintilimab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Global Sintilimab Sales by Manufacturer (2018-2019) (K Units)
Table 21. Global Sintilimab Revenue by Manufacturer (2018-2019) (USD Million)
Table 22. Global Sintilimab Sales by Regions (2015-2020) (K Units)
Table 23. Global Sintilimab Sales Market Share by Regions (2015-2020)
Table 24. Global Sintilimab Revenue by Regions (2015-2020) (USD Million)
Table 25. North America Sintilimab Sales by Countries (2015-2020) (K Units)
Table 26. North America Sintilimab Sales Market Share by Countries (2015-2020)
Table 27. North America Sintilimab Revenue by Countries (2015-2020) (USD Million)
Table 28. North America Sintilimab Revenue Market Share by Countries (2015-2020)
Table 29. Europe Sintilimab Sales by Countries (2015-2020) (K Units)
Table 30. Europe Sintilimab Sales Market Share by Countries (2015-2020)
Table 31. Europe Sintilimab Revenue by Countries (2015-2020) (USD Million)
Table 32. Asia-Pacific Sintilimab Sales by Regions (2015-2020) (K Units)
Table 33. Asia-Pacific Sintilimab Sales Market Share by Regions (2015-2020)
Table 34. Asia-Pacific Sintilimab Revenue by Regions (2015-2020) (USD Million)
Table 35. South America Sintilimab Sales by Countries (2015-2020) (K Units)
Table 36. South America Sintilimab Sales Market Share by Countries (2015-2020)
Table 37. South America Sintilimab Revenue by Countries (2015-2020) (USD Million)
Table 38. South America Sintilimab Revenue Market Share by Countries (2015-2020)
Table 39. Middle East & Africa Sintilimab Sales by Countries (2015-2020) (K Units)
Table 40. Middle East & Africa Sintilimab Sales Market Share by Countries (2015-2020)
Table 41. Middle East & Africa Sintilimab Revenue by Countries (2015-2020) (USD Million)
Table 42. Middle East & Africa Sintilimab Revenue Market Share by Countries (2015-2020)
Table 43. Global Sintilimab Sales by Type (2015-2020) (K Units)
Table 44. Global Sintilimab Sales Share by Type (2015-2020)
Table 45. Global Sintilimab Revenue by Type (2015-2020) (USD Million)
Table 46. Global Sintilimab Revenue Share by Type (2015-2020)
Table 47. Global Sintilimab Sales by Application (2015-2020) (K Units)
Table 48. Global Sintilimab Sales Share by Application (2015-2020)
Table 49. Global Sintilimab Sales Forecast by Regions (2021-2025) (K Units)
Table 50. Global Sintilimab Market Share Forecast by Regions (2021-2025)
Table 51. Global Sintilimab Sales Forecast by Type (2021-2025) (K Units)
Table 52. Global Sintilimab Market Share Forecast by Type (2021-2025)
Table 53. Global Sintilimab Sales Forecast by Application (2021-2025)
Table 54. Global Sintilimab Market Share Forecast by Application (2021-2025)
Table 55. Direct Channel Pros & Cons
Table 56. Indirect Channel Pros & Cons
Table 57. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Sintilimab Picture
Figure 2. Global Sales Market Share of Sintilimab by Type in 2019
Figure 3. 10 ml Picture
Figure 4. Others Picture
Figure 5. Sintilimab Sales Market Share by Application in 2019
Figure 6. Adult Picture
Figure 7. Senior Person Picture
Figure 8. Children Picture
Figure 9. Global Sintilimab Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Sintilimab Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Sintilimab Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Sintilimab Sales Market Share by Manufacturer in 2019
Figure 30. Global Sintilimab Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Sintilimab Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Sintilimab Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Sintilimab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Sintilimab Revenue Market Share by Regions (2015-2020)
Figure 37. Global Sintilimab Revenue Market Share by Regions in 2018
Figure 38. North America Sintilimab Sales and Growth Rate (2015-2020)
Figure 39. Europe Sintilimab Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Sintilimab Sales and Growth Rate (2015-2020)
Figure 41. South America Sintilimab Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Sintilimab Sales and Growth Rate (2015-2020)
Figure 43. North America Sintilimab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Sintilimab Sales Market Share by Countries (2015-2020)
Figure 45. North America Sintilimab Sales Market Share by Countries in 2018
Figure 46. North America Sintilimab Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Sintilimab Revenue Market Share by Countries in 2018
Figure 48. United States Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Sintilimab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Sintilimab Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Sintilimab Revenue Market Share by Countries in 2019
Figure 54. Germany Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Sintilimab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Sintilimab Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Sintilimab Revenue Market Share by Regions 2019
Figure 62. China Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Sintilimab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Sintilimab Sales Market Share by Countries in 2019
Figure 69. South America Sintilimab Revenue Market Share by Countries in 2019
Figure 70. Brazil Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Sintilimab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Sintilimab Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Sintilimab Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Sintilimab Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Sintilimab Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Sintilimab Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Sintilimab Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Sintilimab Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Sintilimab Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Sintilimab Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Sintilimab Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Sintilimab Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
アダルトストアの世界市場（～2026年） Adult Stores sell various products such as couples toys, bullet vibrators, condoms, personal lubricants, erotic lingerie, and sexual enhancement supplements People around the globe, particularly in countries in the Americas and EMEA, are coming out to identify themselves as a part of the lesbian, ga…- 成人用悪性神経膠腫治療薬の世界市場（～2026年） Glioblastoma multiforme (GBM) is among the most difficult of tumors to treat, and despite all efforts, median overall survival remains at approximately 12 months. Malignant gliomas are included in the category of rare diseases, and the orphan drug status is granted for the drug candidates in the pip…
- 成人T細胞白血病/リンパ腫治療の世界市場（～2026年） Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical subtypes (ie, acute, lymphoma, chronic, an…
- 成人用歯ブラシの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Adult Toothbrush market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Adult Toothbrush market repo…
- 成人用心臓血管手術器具パッケージの世界市場（～2026年） Market Analysis and Insights: Global Adult Cardiovascular Surgical Instrument Package Market The global Adult Cardiovascular Surgical Instrument Package market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Adult Cardiovascu…